Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income / (Loss)	Accumulated Deficit
Balance, beginning of period at Jun. 30, 2020	$ 12
Increase (Decrease) in Temporary Equity [Roll Forward]
Preferred share conversion upon initial public offering on August 7, 2020	(12)
Balance, beginning of period (in shares) at Jun. 30, 2020		1,842,000
Balance, beginning of period at Jun. 30, 2020	18,718	$ 0	$ 0	$ 127,710	$ (2,087)	$ (106,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividend distribution to Series A preferred shareholder, 1 share, $4,000 per share	(4,000)					(4,000)
Preferred share conversion upon initial public offering on August 7, 2020 (in shares)		12,985,000
Preferred share conversion upon initial public offering on August 7, 2020	12	$ 2		10
Shares issued through initial public offering on August 7, 2020 (in shares)		3,571,000
Shares issued through initial public offering on August 7, 2020	61,912			61,912
Net income	13,089					13,089
Foreign currency translation adjustment	(650)				(650)
Changes in fair value of cash flow hedges	202				202
Issue of common shares related to option issuances (in shares)		1,000
Issue of common shares related to option issuances	28			28
Provision for common stock warrants	791			791
Changes in defined benefit plan	137				137
Stock based compensation expense	4,510			4,510
Balance, end of period (in shares) at Jun. 30, 2021		18,399,000
Balance, end of period at Jun. 30, 2021	94,749	$ 2	0	194,961	(2,398)	(97,816)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	21,456					21,456
Foreign currency translation adjustment	(2,281)				(2,281)
Changes in fair value of cash flow hedges	(323)				(323)
Issue of common shares related to option issuances (in shares)		3,000
Issue of common shares related to option issuances	35			35
Provision for common stock warrants	$ 970			970
Purchase of treasury shares (in shares)	(227,889)	(228,000)
Purchase of treasury shares	$ (3,406)		(3,406)
Changes in defined benefit plan	440				440
Issue of restricted common shares (in shares)		73,000
Issue of restricted common shares	0
Stock based compensation expense	$ 1,818			1,818
Balance, end of period (in shares) at Jun. 30, 2022	18,246,391	18,247,000
Balance, end of period at Jun. 30, 2022	$ 113,459	$ 2	(3,406)	197,785	(4,562)	(76,360)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	31,582					31,582
Foreign currency translation adjustment	(2,234)				(2,234)
Changes in fair value of cash flow hedges	515				515
Issue of common shares related to option issuances (in shares)		123,000
Issue of common shares related to option issuances	2,053			2,053
Provision for common stock warrants	$ 1,090			1,090
Purchase of treasury shares (in shares)	(17,558)	(18,000)
Purchase of treasury shares	$ (276)		(276)
Changes in defined benefit plan	$ (31)				(31)
Forfeiture of restricted common shares (in shares)	(72,000)
Stock based compensation expense	$ 3,806			3,806
Balance, end of period (in shares) at Jun. 30, 2023	18,280,419	18,280,000
Balance, end of period at Jun. 30, 2023	$ 149,964	$ 2	$ (3,682)	$ 204,734	$ (6,312)	$ (44,778)